Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Dengue
SAGE documentation
Evidence to recommendation table
Clear all
Type of publications
SAGE documentation
(4)
Topics
Evidence to recommendation table
(4)
Regions
Countries
Diseases
COVID-19
(2)
Dengue
(2)
Diphtheria
(1)
Hepatitis B
(2)
Human papillomavirus (HPV)
(3)
Influenza
(1)
Malaria
(2)
Measles
(2)
Mpox // Monkeypox
(1)
Pertussis
(1)
Pneumococcal disease
(2)
Rabies
(2)
Rubella
(2)
Tuberculosis
(6)
Typhoid
(1)
Publication date
2022
(1)
2021
(1)
2018
(2)
Target population
Available to download in languages
English (EN)
(4)
4 results found
2022
∙
SAGE
Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
2021
∙
SAGE
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
2018
∙
SAGE
Should countries considering introduction of CYD-TDV to reduce the burden of dengue use a pre-vaccination screening or population seroprevalence based criteria?
2018
∙
SAGE
Should CYD-TDV be recommended, over no vaccination, to immunocompetent individuals (≥9 years of age) in dengueendemic countries to mitigate the dengue burden of disease?
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register